Molecular phylogenetic diversity of the emerging mucoralean fungus Apophysomyces: Proposal of three new species;Diversidad filogenética del hongo mucoral emergente Apophysomyces: Propuesta de tres nuevas especies.

Revista Iberoamericana de Micologia

Volumn 27, Issue 2, 2010, Pages 80-89

  Alvarez, Eduardo ^a   Stchigel, Alberto M ^a   Cano, Josep ^a   Sutton, Deanna A ^b   Fothergill, Annette W ^b   Chander, Jagdish ^c   Salas, Valentina ^a   Rinaldi, Michael G ^b   Guarro, Josep ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Apophysomyces elegans; Apophysomyces ossiformis; Apophysomyces trapeziformis; Apophysomyces variabilis; Phylogeny; Taxonomy; Zygomycetes

Indexed keywords

AMPHOTERICIN B; ANIDULAFUNGIN; CARBON; CASPOFUNGIN; ESCULIN; GLYCOSIDE; HISTONE H3; INTERNAL TRANSCRIBED SPACER; ITRACONAZOLE; NITROGEN; POSACONAZOLE; RAVUCONAZOLE; RIBOSOME DNA; RIBOSOME RNA; VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; APOPHYSOMYCES; APOPHYSOMYCES ELEGANS; APOPHYSOMYCES OSSIFORMIS; APOPHYSOMYCES TRAPEZIFORMIS; APOPHYSOMYCES VARIABILIS; ARTICLE; CARBON FIXATION; CONTROLLED STUDY; FUNGAL MORPHOLOGY; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC VARIABILITY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR PHYLOGENY; MUCORALES; NEW SPECIES; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN DOMAIN; SPORANGIOSPORE; STRAIN DIFFERENCE;

CARBON; COMMUNICABLE DISEASES, EMERGING; DNA, FUNGAL; FUNGAL PROTEINS; GENETIC VARIATION; HISTONES; HUMANS; IMMUNOCOMPETENCE; IMMUNOCOMPROMISED HOST; MOLECULAR SEQUENCE DATA; MUCORALES; MUCORMYCOSIS; PHYLOGENY; RNA, FUNGAL; RNA, RIBOSOMAL, 28S; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY, NUCLEIC ACID; SOIL MICROBIOLOGY; SPECIES SPECIFICITY; SPORES, FUNGAL;

APOPHYSOMYCES; APOPHYSOMYCES ELEGANS; FUNGI; MUCORALES; ZYGOMYCETES;

EID: 77954690441     PISSN: 11301406     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.riam.2010.01.006     Document Type: Article

References (27)

1. Alastruey-Izquierdo A., Castelli M.V., Cuesta I., Monzón A., Cuenca-Estrella M., Rodríguez-Tudela J.L. Activity of posaconazole and other antifungal agents against mucorales strains identified by sequencing of internal transcribed spacers. Antimicrob Agents Chemother 2009, 53:1686-1689.
2. Almyroudis N.G., Sutton D.A., Fothergill A.W., Rinaldi M.G., Kusne S. In vitro susceptibilities of 217 clinical isolates of zygomycetes to conventional and new antifungal agents. Antimicrob Agents Chemother 2007, 51:2587-2590.
3. Álvarez E., Sutton D.A., Cano J., Fothergill A.W., Stchigel A., Rinaldi M.G., et al. Spectrum of zygomycete species identified in clinically significant specimens in the United States. J Clin Microbiol 2009, 47:1650-1656.
4. Andresen D., Donaldson A., Choo L., Knox A., Klaassen M., Ursic C., et al. Multifocal cutaneous mucormycosis complicating polymicrobial wound infections in a tsunami survivor from Sri Lanka. Lancet 2005, 365:876-878.
5. Chakrabarti A., Ghosh A., Prasad G.S., David J.K., Gupta S., Das A., et al. Apophysomyces elegans: an emerging zygomycete in India. J Clin Microbiol 2003, 41:783-788.
6. Cooter R.D., Lim I.S., Ellis D.H., Leitch I.O.W. Burn wound zygomycosis caused by Apophysomyces elegans. J Clin Microbiol 1990, 28:2151-2153.
7. Dannaoui E., Meletiadis J., Mouton J.W., Meis J.F., Verweij P.E. In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 2003, 51:45-52.
8. de Hoog G.S., Guarro J., Gené J., Figueras M.J. Atlas of clinical fungi 2000, Utrecht, The Netherlands, Centraalbureau voor Schimmelcultures. 2nd ed.
9. de Hoog G.S., Marvin-Sikkema F.D., Lahpoor G.A., Gottschall J.C., Prins R.A., Guého E. Ecology and physiology of the emerging opportunistic fungi Pseudallescheria boydii and Scedosporium prolificans. Mycoses 1994, 37:71-78.
10. Glass N.L., Donaldson G.C. Development of primer sets designed for use with the PCR to amplify conserved genes from filamentous ascomycetes. Appl Environ Microbiol 1995, 61:1323-1330.
11. Hibbett D.S., Binder M., Bischoff J.F., Blackwell M., Cannon P.F., Eriksson O.E., et al. A higher level phylogenetic classification of the fungi. Mycol Res 2007, 111:509-547.
12. Kimura M., Smith M.B., McGinnis M.R. Zygomycosis due to Apophysomyces elegans: report of 2 cases and review of the literature. Arch Pathol Lab Med 1999, 123:386-390.
13. Kindo A.J., Shams N.R., Kumar K., Kannan S., Vidya S., Kumar A.R., et al. Fatal cellulitis caused by Apophysomyces elegans. Indian J Med Microbiol 2007, 25:285-287.
14. Lakshmi V., Suda Rani T., Sharma S., Mohan V.S., Sundaram C., Rao R.R., et al. Zygomycotic necrotising fasciitis caused by Apophysomyces elegans. J Clin Microbiol 1993, 31:1368-1369.
15. Liang K.P., Tleyjeh I.M., Wilson W.R., Roberts G.D., Temesgen Z. Rhino-orbitocerebral mucormycosis caused by Apophysomyces elegans. J Clin Microbiol 2006, 44:892-898.
16. Marimon R., Gené J., Cano J., Trilles L., Dos Santos Lazéra M., Guarro J. Molecular phylogeny of Sporothrix schenckii. J Clin Microbiol 2006, 44:3251-3256.
17. Meis J.F., Chakrabarti A. Changing epidemiology of an emerging infection: zygomicosis. Clin Microbiol Infect 2009, 15(Suppl. 5):10-14.
18. Misra P.C., Srivastava K.J., Lata K. Apophysomyces, a new genus of the Mucorales. Mycotaxon 1979, 8:377-382.
19. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi: approved standard-second edition. Document M38-A2 2008, National Committee for Clinical Laboratory Standards, Wayne, Pa, National Committee for Clinical Laboratory Standards.
20. Page R., Gardam D.J., Heath C.H. Severe cutaneous mucormycosis (zygomycosis) due to Apophysomyces elegans. Aust N Z J Surg 2001, 71:184-186.
21. Ruiz C.E., Arango M., Correa A.L., López L.S., Restrepo A. Necrotizing fasciitis in an immunocompetent patient caused by Apophysomyces elegans. Biomedica 2004, 24:239-251.
22. Saravia-Flores M., Guaran D.M., Argueta V. Invasive cutaneous infection caused by Apophysomyces elegans associated with a spider bite. Mycoses 2010, doi:10.1111/j.1439-0507.2009.01698.x.
23. Schwarz P., Lortholary O., Dromer F., Dannaoui E. Carbon assimilation profiles as a tool for identification of zygomycetes. J Clin Microbiol 2007, 45:1433-1439.
24. Snell B.J., Tavakoli K. Necrotizing fasciitis caused by Apophysomyces elegans complicating soft-tissue and pelvic injuries in a tsunami survivor from Thailand. Plast Reconstr Surg 2007, 119:448-449.
25. Sun Q.N., Fothergill A.W., McCarthy D.I., Rinaldi M.G., Graybill J.R. In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes. Antimicrob Agents Chemother 2002, 46:1581-1582.
26. Suryanarayan Rao S., Panda N.K., Pragache G., Chakrabarti A., Saravanan K. Sinoorbital mucormycosis due to Apophysomyces elegans in immunocompetent individuals-an increasing trend. Am J Otolaryngol 2006, 27:366-369.
27. Yarrow D. Methods for the isolation, maintenance and identification of yeasts. In: Kurtzman CP, Fell JW, editors. The yeasts, a taxonomic study, 4th ed. Amsterdam, The Netherlands: Elsevier; 1998. p. 95-7.